GIUDICE, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 11.423
EU - Europa 7.570
NA - Nord America 7.458
SA - Sud America 787
Continente sconosciuto - Info sul continente non disponibili 317
AF - Africa 165
OC - Oceania 19
Totale 27.739
Nazione #
HK - Hong Kong 7.430
US - Stati Uniti d'America 7.244
FI - Finlandia 3.922
SG - Singapore 1.916
IT - Italia 1.539
CN - Cina 763
BR - Brasile 586
DE - Germania 565
VN - Vietnam 534
RU - Federazione Russa 448
ES - Italia 198
IN - India 170
FR - Francia 166
GB - Regno Unito 147
UA - Ucraina 129
IE - Irlanda 128
CA - Canada 116
KR - Corea 111
TR - Turchia 95
BD - Bangladesh 92
AR - Argentina 91
SE - Svezia 68
AT - Austria 55
JP - Giappone 55
NL - Olanda 50
MX - Messico 45
ZA - Sudafrica 45
CZ - Repubblica Ceca 41
PL - Polonia 41
ID - Indonesia 38
IQ - Iraq 37
EC - Ecuador 31
PK - Pakistan 25
ET - Etiopia 24
CO - Colombia 23
UZ - Uzbekistan 21
EG - Egitto 20
MA - Marocco 19
MY - Malesia 18
VE - Venezuela 17
SA - Arabia Saudita 16
AU - Australia 14
CL - Cile 14
PY - Paraguay 13
TN - Tunisia 13
KE - Kenya 12
NP - Nepal 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
HN - Honduras 11
JM - Giamaica 10
JO - Giordania 10
BE - Belgio 8
EU - Europa 8
LT - Lituania 8
AL - Albania 7
DZ - Algeria 7
KZ - Kazakistan 7
TH - Thailandia 7
CR - Costa Rica 6
NI - Nicaragua 6
PE - Perù 6
PT - Portogallo 6
IL - Israele 5
KG - Kirghizistan 5
MD - Moldavia 5
AO - Angola 4
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HR - Croazia 4
LY - Libia 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
BJ - Benin 3
GE - Georgia 3
HU - Ungheria 3
IR - Iran 3
LB - Libano 3
LU - Lussemburgo 3
NO - Norvegia 3
OM - Oman 3
PR - Porto Rico 3
SC - Seychelles 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LC - Santa Lucia 2
LV - Lettonia 2
RS - Serbia 2
SR - Suriname 2
Totale 27.403
Città #
Hong Kong 7.407
Helsinki 3.822
San Jose 969
Singapore 955
Ashburn 646
Dallas 628
Milan 525
Ann Arbor 465
Chandler 453
Munich 390
Woodbridge 326
Council Bluffs 319
Princeton 305
Beijing 223
Wilmington 190
Houston 176
Los Angeles 168
Valencia 157
Rome 156
Jacksonville 150
Naples 148
Ho Chi Minh City 141
Lauterbourg 140
New York 126
Santa Clara 124
The Dalles 116
Dong Ket 112
Dublin 112
Moscow 91
Hanoi 87
São Paulo 73
Nuremberg 70
Salerno 68
Orem 63
Izmir 58
Andover 57
Buffalo 56
Figino 45
Boardman 44
Turku 43
Brooklyn 42
Phoenix 42
Tokyo 41
Turin 40
Chennai 37
Warsaw 37
Brno 36
Washington 36
Memphis 35
Nanjing 35
Redwood City 35
Montreal 33
Atlanta 32
Frankfurt am Main 32
Chicago 31
Johannesburg 31
Stockholm 31
Amsterdam 30
London 30
Seattle 29
Manchester 27
Rio de Janeiro 27
Denver 26
Toronto 26
Addis Ababa 24
Fisciano 24
Pune 24
Pellezzano 23
Vienna 22
Mumbai 19
Boston 18
Changsha 18
Columbus 18
Düsseldorf 18
Fairfield 18
Haiphong 18
Jyväskylä 17
Tashkent 17
Baghdad 16
Belo Horizonte 16
Brasília 16
Mexico City 16
Poplar 16
Da Nang 15
Hải Dương 15
Philadelphia 15
San Francisco 15
Seoul 15
Curitiba 14
Norwalk 14
Charlotte 13
Tianjin 13
Ankara 12
Dhaka 12
Lahore 12
Lappeenranta 12
Nanchang 12
Quito 12
Shanghai 12
Cairo 11
Totale 21.587
Nome #
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 2.033
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1.990
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 901
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 716
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 678
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 581
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 500
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 498
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 495
Aplastic anemia: Pathophysiology 492
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 421
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 367
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 348
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 340
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 337
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 327
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 321
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 319
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 301
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 260
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 251
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 233
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 233
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 231
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 220
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 203
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 200
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 200
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 196
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 194
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 193
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 188
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 186
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 185
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 185
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 176
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 173
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 171
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 170
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 168
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 159
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 158
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 157
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 156
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 150
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 148
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 146
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 144
Pre- and Post-COVID-19 Antibiotic Consumption and Stewardship Program in a Southern Italian Hospital 143
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 143
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 141
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 138
Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study 136
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 136
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 135
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 134
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 134
BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient 133
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 131
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 130
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 128
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 126
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 125
Advanced biopolymer filtration system for Peripheral Blood Mononuclear Cells collection: a study on filter composition and in vitro filtrate composition 124
COVID-19 vaccine-associated lymphadenopathy: a review 124
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 123
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 121
Stem cell and macrophage roles in skeletal muscle regenerative medicine 117
Endocrine disorders after autologous and allogeneic stem cell transplantation 116
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 114
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 113
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 113
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 113
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 112
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 112
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine 109
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 109
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 108
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 106
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 105
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 104
Clinical Utility of TRBC1 Addition in Multiparametric Flow Cytometry for T Cell Lymphoma Diagnosis 104
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 104
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 103
OPSI threat in hematological patients 103
Sicurezza del vaccino ricombinante anti-herpes Zoster virus in popolazioni fragili: uno studio osservzionale 101
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 100
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 96
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 96
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience 95
A case series of blastic plasmacytoid dendritic cell neoplasia 94
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 93
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 92
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 92
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 91
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 89
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 89
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 88
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 88
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 87
Totale 23.260
Categoria #
all - tutte 75.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022553 0 0 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.716 76 36 42 84 173 277 662 249 447 122 253 295
2025/202619.418 1.420 3.933 3.465 739 1.158 474 1.320 277 4.389 920 225 1.098
2026/2027820 306 375 139 0 0 0 0 0 0 0 0 0
Totale 27.739